The effect of inhaled dry salt on pulmonary mucociliary clearance in obstructive lung disease: A randomised, placebo‐controlled, crossover study
Clinical Physiology and Functional Imaging · 2026-05 · 46 (3)
DOI: 10.1111/cpf.70060 ↗At a glance
Randomisierte kontrollierte Studie in Clinical Physiology and Functional Imaging, published online on 2026-04-01. Written by Rie Skovly Thomsen and 7 co-authors. Institution: Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark. Major MEDLINE topics: Mucociliary Clearance, Pulmonary Disease, Chronic Obstructive, Sodium Chloride, Lung. 23 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Liita Care.
Abstract (original language)
Background
Inhaled saline may improve mucus transport in respiratory diseases, for example, cystic fibrosis. This randomised, placebo‐controlled, crossover study examined the effect of inhaled dry NaCl on mucociliary clearance in patients with chronic obstructive pulmonary disease (COPD).
Methods
Twenty‐five patients with GOLD stage I‐III COPD (72% with excess mucus) were tested on two separate days after inhalation from a dry powder inhaler containing either 40 mg dry NaCl or placebo (empty). Pulmonary mucociliary clearance was assessed using inhalation of a radioactive 99m Tc‐labelled nanocolloid tracer and gamma camera imaging. Clearance was measured for 2 h post‐intervention. Co‐primary outcomes were clearance after 1 and 2 h.
Results
The study was terminated early due to COVID‐19 after enrolling 25 of 35 planned patients. No significant differences were observed in mucociliary clearance between NaCl and placebo after 1 h (11.3% ± 9.0% vs. 11.4% ± 7.0%, p = 0.97) or 2 h (15.3% ± 9.8% vs.16.1% ± 8.7%, p = 0.55). Normalised clearance based on initial radioaerosol deposition also showed no difference.
Conclusions
Inhalation of 40 mg dry NaCl was well tolerated without acute adverse effects in COPD patients. However, early termination left the study underpowered, increasing the risk of type II error. Non‐significant findings should not be interpreted as evidence of no effect. Larger, adequately powered trials are needed to clarify the impact of dry NaCl inhalation on mucociliary clearance in COPD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
- Centre for Physical Activity Research, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
- Department of Nuclear Medicine, Aalborg University Hospital, Aalborg, Denmark.
- Department of Gastroenterology and Hepatology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Neurovascular Research Laboratory, Faculty of Life Sciences and Education, University of South Wales, Pontypridd, UK.
ORCID profiles: Mohamed Attauabi, Jann Mortensen
Funding
- Liita Care
Cite
APA
Thomsen, R. S., Mikkelsen, C., Olsen, N. E., Einarsdóttir, H. S., Attauabi, M., Berg, R. M. G., Harboe, H., & Mortensen, J. (2026). The effect of inhaled dry salt on pulmonary mucociliary clearance in obstructive lung disease: A randomised, placebo‐controlled, crossover study. Clinical Physiology and Functional Imaging, 46(3). https://doi.org/10.1111/cpf.70060
Vancouver
Thomsen RS, Mikkelsen C, Olsen NE, Einarsdóttir HS, Attauabi M, Berg RMG, et al. The effect of inhaled dry salt on pulmonary mucociliary clearance in obstructive lung disease: A randomised, placebo‐controlled, crossover study. Clinical Physiology and Functional Imaging. 2026;46(3). doi:10.1111/cpf.70060
BibTeX
@article{Thomsen2026,
author = {Thomsen, Rie Skovly and Mikkelsen, Clara and Olsen, Naja Enevold and Einarsdóttir, Hrefna Sæunn and Attauabi, Mohamed and Berg, Ronan M G and Harboe, Henrik and Mortensen, Jann},
title = {The effect of inhaled dry salt on pulmonary mucociliary clearance in obstructive lung disease: A randomised, placebo‐controlled, crossover study},
journal = {Clinical Physiology and Functional Imaging},
year = {2026},
volume = {46},
number = {3},
doi = {10.1111/cpf.70060}
}
EUVIMED